These insider sales are immaterial and likely driven by routine portfolio diversification or tax planning. No actionable signal; focus on upcoming pipeline catalysts for IONS.
IONS drugs
IONS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 10 $58.25entry
- T+1 · 4mo ago −2.93%α −2.15% · $56.54
- T+5 · 4mo ago −6.18%α −5.62% · $54.65
- T+20 · 3mo ago −2.90%α −5.33% · $56.56
- T+60 · 6w ago −25.32%α −27.96% · $43.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of insider sales at Ionis Pharmaceuticals (IONS) totaling $1.36M over a 7-day window, involving the Chief Scientific Officer, Chief Development Officer, and two directors. The total value represents only ~0.01% of the company's $14B market cap, making the sales immaterial and likely routine portfolio diversification or tax-related. No actionable signal for traders.
Key Financial Metrics
Key Facts
- Four insiders sold shares: EVP/CSO Bennett ($463K), Director Diaz ($864K), EVP/CDO Kordasiewicz ($31K), and Director Klein ($8K)
- Total open-market proceeds: $1.36M
- Sales represent ~0.01% of IONS' $14B market cap
- No CEO or CFO participated in the sales
- No other material corporate events (earnings, M&A, restructuring) accompanied this cluster
Financial Impact
Insider sales totaling $1.36M, representing 0.01% of $14B market cap, negligible relative to company size.
Risk Factors
- No material risk identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IONS-1783639622793 |
Track record
26 reports on IONS
7 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +32.25% at T+60 after the Jul 9, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 9, 20267d ago 8-K Bearish 6/10 Entry $31.00 to $28.01 Now $28.01 +9.65% ▲ +9.65% +7.95% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $44.90 to $40.15 Now $28.01 −37.62% ▼ −10.58% −9.87% vs SPY
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $42.93 to $43.52 Now $28.01 −34.75% ▲ +1.37% +1.93% vs SPY
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $43.91 to $44.39 Now $28.01 −36.21% ▲ +1.09% +0.39% vs SPY
- Oct 21, 202626d ago Institutional Cluster Mixed 3/10 Entry $43.91 to $44.39 Now $28.01 −36.21% ▲ +1.09% +0.39% vs SPY
- Sep 23, 20267w ago 8-K Bullish 7/10 Entry $43.93 to $44.65 Now $28.01 −36.24% ▲ +1.64% +2.31% vs SPY
- Sep 4, 202610w ago 8-K Bearish 7/10 Entry $56.71 to $47.25 Now $28.01 +50.61% ▲ +16.68% +15.56% vs SPY
- Sep 4, 202610w ago 8-K Bullish 7/10 Entry $58.09 to $51.44 Now $28.01 −51.78% ▼ −11.45% −10.24% vs SPY
- Jul 31, 202615w ago Insider Buy Neutral 4/10 Entry $54.49 to $56.94 Now $28.01 −48.60% ▲ +4.50% +2.47% vs SPY
- Jul 29, 202615w ago 8-K Neutral 5/10 Entry $54.04 to $54.19 Now $28.01 −48.17% ▲ +0.28% −5.25% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers